{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:32:09Z","timestamp":1783031529531,"version":"3.54.6"},"reference-count":28,"publisher":"Universa BV","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Orthop Belg"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Early periprosthetic joint infection (PJI) is generally treated by means of debridement, antibiotics and implant retention (DAIR). Subsequently, empiric antibiotic therapy is commenced directly after surgery which is important for the successful treatment of PJI. The aim of this study is to evaluate current nationwide empiric antibiotic treatment regimens for PJI in the Netherlands. An electronic 15-question survey addressing the empiric antibiotic treatment strategy for PJI following THA or TKA was sent to orthopaedic surgeons in all Dutch hospitals in April 2019. Orthopaedic surgeons active in every single Dutch orthopaedic hospital (n=69) were approached. At least one surgeon in every hospital completed the survey (100% response rate). A protocol dictating the empiric antibiotic treatment following DAIR was used in 87% (60 hospitals). Among all hospitals, 72% (50 hospitals) used antibiotic monotherapy and 28% (19 hospitals) used combination therapy. Cefazolin was the most commonly used regimen in centres opting for monotherapy (42%, 29 hospitals). Similar regimens were used for the empiric treatment of suspected early PJI after revision surgery and for acute hematogenous PJI. In septic patients, combination therapy was preferred (64%). 81% (56 hospitals) incubated tissue biopsies for a minimum of 10 days whereas 16% (9 hospitals) indicated an incubation period of 7 days or less. Even in a small country such as the Netherlands there seems to be no uniformity regarding empiric antibiotic treatment for PJI. Increased uniformity regarding empiric treatment could be an important first step in improving PJI treatment.<\/jats:p>","DOI":"10.52628\/89.4.9415","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T01:16:37Z","timestamp":1704935797000},"page":"665-669","source":"Crossref","is-referenced-by-count":2,"title":["Empiric antibiotic treatment for periprosthetic joint infections: a national survey in The Netherlands"],"prefix":"10.52628","volume":"89","author":[{"given":"R","family":"SCHOLTEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.C.","family":"KLEIN KLOUWENBERG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.C.","family":"VAN SUSANTE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"SOMFORD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27062","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010; 468: 45-51.","DOI":"10.1007\/s11999-009-0945-0"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009; 91: 128-33.","DOI":"10.2106\/jbjs.h.00155"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. The Journal of bone and joint surgery American volume. 2007; 89: 780-5.","DOI":"10.2106\/00004623-200704000-00012"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004 Oct 14;351(16):1645-54. doi: 10.1056\/NEJMra040181. PMID: 15483283.","DOI":"10.1056\/nejmra040181"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Fernandez-Sampedro M, Farinas-Alvarez C, Garces-Zarzalejo C, Alonso-Aguirre MA, Salas-Venero C, Martinez-Martinez L, et al. Accuracy of different diagnostic tests for early, delayed and late prosthetic joint infection. BMC infectious diseases. 2017; 17: 592.","DOI":"10.1186\/s12879-017-2693-1"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013; 56: e1-e25.","DOI":"10.1093\/cid\/cis803"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Peel TN, Cheng AC, Choong PF, Buising KL. Early onset prosthetic hip and knee joint infection: treatment and outcomes in Victoria, Australia. The Journal of hospital infection. 2012; 82: 248-53.","DOI":"10.1016\/j.jhin.2012.09.005"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Puhto AP, Puhto T, Niinimaki T, Ohtonen P, Leppilahti J, Syrjala H. Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention. International orthopaedics. 2015; 39: 1785-91.","DOI":"10.1007\/s00264-015-2819-2"},{"key":"ref8","unstructured":"Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery. 1961; 50: 161-8."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Parvizi J, Gehrke T. International consensus on periprosthetic joint infection: let cumulative wisdom be a guide. The Journal of bone and joint surgery American volume. 2014; 96: 441.","DOI":"10.2106\/jbjs.n.00023"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Li ZL, Hou YF, Zhang BQ, Chen YF, Wang Q, Wang K, et al. Identifying Common Pathogens in Periprosthetic Joint Infection and Testing Drug-resistance Rate for Different Antibiotics: A Prospective, Single Center Study in Beijing. Orthopaedic surgery. 2018; 10: 235-40.","DOI":"10.1111\/os.12394"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Fulkerson E, Valle CJ, Wise B, Walsh M, Preston C, Di Cesare PE. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. The Journal of bone and joint surgery American volume. 2006; 88: 1231-7.","DOI":"10.2106\/00004623-200606000-00009"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Ravi S, Zhu M, Luey C, Young SW. Antibiotic resistance in early periprosthetic joint infection. ANZ journal of surgery. 2016; 86: 1014-8.","DOI":"10.1111\/ans.13720"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. The Journal of infection. 2007; 55: 1-7.","DOI":"10.1016\/j.jinf.2007.01.007"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Aggarwal VK, Bakhshi H, Ecker NU, Parvizi J, Gehrke T, Kendoff D. Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States. The journal of knee surgery. 2014; 27: 399-406.","DOI":"10.1055\/s-0033-1364102"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra- Kumar S, Peschel A, et al. Methicillin-resistant Staphylococcus aureus. Nature reviews Disease primers. 2018; 4: 18033.","DOI":"10.1038\/nrdp.2018.33"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Minassian AM, Osmon DR, Berendt AR. Clinical guidelines in the management of prosthetic joint infection. The Journal of antimicrobial chemotherapy. 2014; 69 Suppl 1: i29-35.","DOI":"10.1093\/jac\/dku253"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends in microbiology. 2005;13: 34-40.","DOI":"10.1016\/j.tim.2004.11.010"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Mathur T, Singhal S, Khan S, Upadhyay D, Fatma T, Rattan A. Adverse effect of staphylococci slime on in vitro activity of glycopeptides. Japanese journal of infectious diseases. 2005;58: 353-7.","DOI":"10.7883\/yoken.JJID.2005.353"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Kostenko V, Ceri H, Martinuzzi RJ. Increased tolerance of Staphylococcus aureus to vancomycin in viscous media. FEMS immunology and medical microbiology. 2007; 51: 277-88.","DOI":"10.1111\/j.1574-695x.2007.00300.x"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Souli M, Giamarellou H. Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. Antimicrobial agents and chemo- therapy. 1998; 42: 939-41.","DOI":"10.1128\/aac.42.4.939"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Konig C, Schwank S, Blaser J. Factors compromising antibiotic activity against biofilms of Staphylococcus epidermidis. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2001; 20: 20-6.","DOI":"10.1007\/pl00011232"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. The Journal of infectious diseases. 1990; 161: 37-40.","DOI":"10.1093\/infdis\/161.1.37"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Sendi P, Zimmerli W. The use of rifampin in staphylococcal orthopaedic-device-related infections. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2017; 23: 349-50.","DOI":"10.1016\/j.cmi.2016.10.002"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Svensson E, Hanberger H, Nilsson M, Nilsson LE. Factors affecting development of rifampicin resistance in biofilm- producing Staphylococcus epidermidis. The Journal of antimicrobial chemotherapy. 1997; 39: 817-20.","DOI":"10.1093\/jac\/39.6.817"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Valentin T, Leitner E, Rohn A, Zollner-Schwetz I, Hoenigl M, Salzer HJ, et al. Rifaximin intake leads to emergence of rifampin-resistant staphylococci. The Journal of infection. 2011; 62: 34-8.","DOI":"10.1016\/j.jinf.2010.11.004"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrobial agents and chemotherapy. 2006; 50: 55-61.","DOI":"10.1128\/aac.50.1.55-61.2006"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Scheper H, van Hooven D, van de Sande M, van der Wal R, van der Beek M, Visser L, et al. Outcome of acute staphylococcal prosthetic joint infection treated with debridement, implant retention and antimicrobial treatment with short duration of rifampicin. The Journal of infection. 2018; 76: 498-500","DOI":"10.1016\/j.jinf.2018.01.009"}],"container-title":["Acta Orthopaedica Belgica"],"original-title":[],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T21:34:01Z","timestamp":1731015241000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.actaorthopaedica.be\/archive\/volume-89\/issue-4\/original-studies\/empiric-antibiotic-treatment-for-periprosthetic-joint-infections-a-national-survey-in-the-netherland\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,1]]},"published-print":{"date-parts":[[2023,12]]}},"URL":"https:\/\/doi.org\/10.52628\/89.4.9415","relation":{},"ISSN":["0001-6462"],"issn-type":[{"value":"0001-6462","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}